A retrograde step to 30-day packs
I note with dismay the announcement in the PJ that the Femara packaging has been switched from a 28-pack to 30-day pack. (PJ 2014;292:292).
At this time when we should be helping patients with their medicines as part of our medicines optimisation initiatives, I believe this is a retrograde step by Novartis. Moving from a 28-day calendar pack to a 30-day pack will not be of any benefit to patients who may be on this medicine for up to 10 years.
All patient packs should be calendar packs, where appropriate, and should be in multiples of 28. The Royal Pharmaceutical Society should be pressing the Medicines and Healthcare products Regulatory Agency and the manufacturers to switch to 28-day calendar packs.
Hopefully, the generic manufacturers of letrozole will not be following this example.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11137456
Recommended from Pharmaceutical Press